Cargando…

Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

BACKGROUND: Several recent studies have shown that angiotensin type 1 receptor (AT1) antagonists such as candesartan inhibit the microglial inflammatory response and dopaminergic cell loss in animal models of Parkinson's disease. However, the mechanisms involved in the neuroprotective and anti-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garrido-Gil, Pablo, Joglar, Belen, Rodriguez-Perez, Ana I, Guerra, Maria J, Labandeira-Garcia, Jose L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298706/ https://www.ncbi.nlm.nih.gov/pubmed/22356806 http://dx.doi.org/10.1186/1742-2094-9-38

Ejemplares similares

Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator
por: Hamano, Yuki, et al.
Publicado: (2011)

PPARγ Agonist and Angiotensin II Receptor Antagonist Ameliorate Renal Tubulointerstitial Fibrosis
por: Han, Jee-Young, et al.
Publicado: (2010)

Telmisartan Potentiates Insulin Secretion via Ion Channels, Independent of the AT1 Receptor and PPARγ
por: Liu, Tao, et al.
Publicado: (2021)

Telmisartan, an Antagonist of Angiotensin II Receptors, Accentuates Voltage-Gated Na(+) Currents and Hippocampal Neuronal Excitability
por: Lai, Ming-Chi, et al.
Publicado: (2020)

Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γ Agonist against MPTP
por: Swanson, Christine R., et al.
Publicado: (2013)

Effects of a PPAR -gamma receptor agonist and an angiotensin receptor antagonist on aortic contractile responses to alpha receptor agonists in diabetic and/or hypertensive rats
por: Tugrul, Ibrahim, et al.
Publicado: (2016)

Renin angiotensin system and gender differences in dopaminergic degeneration
por: Rodriguez-Perez, Ana I, et al.
Publicado: (2011)

Angiotensin receptor blocker telmisartan suppresses renal gluconeogenesis during starvation
por: Tojo, Akihiro, et al.
Publicado: (2015)

Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway
por: Feng, Xiaoli, et al.
Publicado: (2011)

Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra
por: Grammatopoulos, Tom N, et al.
Publicado: (2007)

Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
por: Ayza, Muluken Altaye, et al.
Publicado: (2020)

Effects of adenosine receptor antagonists in MPTP mouse model of Parkinson’s disease: mitochondrial DNA integrity
por: Essawy, Soha S., et al.
Publicado: (2017)

Involvement of PPARγ in the Anticonvulsant Activity of EP-80317, a Ghrelin Receptor Antagonist
por: Lucchi, Chiara, et al.
Publicado: (2017)

Nuclear receptor corepressors and PPARγ
por: Cohen, Ronald N.
Publicado: (2006)

Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
por: Rodriguez-Perez, Ana I., et al.
Publicado: (2018)

Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan
por: Park, Jung Gyu, et al.
Publicado: (2019)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

Angiotensin II receptor blocker telmisartan attenuates aortic stiffening and remodelling in STZ-diabetic rats
por: Salum, Erik, et al.
Publicado: (2014)

Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011)

Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
por: Labandeira, Carmen M., et al.
Publicado: (2022)

Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin–angiotensin system in the nigra
por: Garrido-Gil, Pablo, et al.
Publicado: (2012)

Role of Vascular Smooth Muscle PPARγ in Regulating AT(1) Receptor Signaling and Angiotensin II-Dependent Hypertension
por: Carrillo-Sepulveda, Maria Alicia, et al.
Publicado: (2014)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer
por: Belfiore, A., et al.
Publicado: (2009)

Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent Antagonists
por: Fratev, Filip, et al.
Publicado: (2015)

The Role of PPARγ Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer
por: Adrian, Thomas E., et al.
Publicado: (2008)

Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T‐cell leukemia cells
por: Kozako, Tomohiro, et al.
Publicado: (2016)

Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest
por: Samukawa, Eri, et al.
Publicado: (2017)

The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKa/mTOR pathway in vitro and in vivo
por: Fujihara, Shintaro, et al.
Publicado: (2016)

Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours
por: Marques, A R, et al.
Publicado: (2004)

Neuroprotective effect of angiotensin II type 2 receptor during cerebral ischemia/reperfusion
por: Ma, Chun-ye, et al.
Publicado: (2016)

Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection
por: Attia, Yasmeen M, et al.
Publicado: (2013)

Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench
por: Chang, Wei-Ting, et al.
Publicado: (2016)

Telmisartan Exerts Anti-Tumor Effects by Activating Peroxisome Proliferator-Activated Receptor-γ in Human Lung Adenocarcinoma A549 Cells
por: Li, Juan, et al.
Publicado: (2014)

Retinal Neuroprotective Effects of Flibanserin, an FDA-Approved Dual Serotonin Receptor Agonist-Antagonist
por: Coyner, Aaron S., et al.
Publicado: (2016)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

The Role of Peroxisome Proliferator-Activated Receptor and Effects of Its Agonist, Pioglitazone, on a Rat Model of Optic Nerve Crush: PPARγ in Retinal Neuroprotection
por: Zhu, Juming, et al.
Publicado: (2013)

Spectrofluorimetric method for determination of some angiotensin II receptor antagonists
por: El-Shaboury, Salwa R., et al.
Publicado: (2012)

Angiotensin II receptor antagonists a potential therapy for SARS
Publicado: (2013)

Receptors | Angiotensin Receptors
por: Pardhi, Triveni R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s2q57caean735sngjss02o8jv3